Antenatal care attendees positive for syphilis who received treatment in El Salvador
El Salvador: Antenatal care attendees positive for syphilis who received treatment was 56.1% in 2021. ◆ Volatile
Antenatal care attendees positive for syphilis who received treatment in El Salvador, 2011–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, antenatal care attendees positive for syphilis who received treatment in El Salvador stood at 56.1%.
The figure is up 228.1% on the previous year and up 131.8% over ten years.
Over the whole period, antenatal care attendees positive for syphilis who received treatment in El Salvador peaked at 61.5% in 2015 and was at its lowest, 9.7%, in 2016.
That places El Salvador 70th out of 79 countries with data for 2021, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antenatal care attendees positive for syphilis who received treatment in El Salvador, year by year
| Year | Value | Change |
|---|---|---|
| 2011 | 24.2% | — |
| 2012 | 12.3% | -49.2% |
| 2013 | 29.9% | +143.1% |
| 2015 | 61.5% | +105.7% |
| 2016 | 9.7% | -84.2% |
| 2017 | 50.6% | +421.6% |
| 2018 | 34.9% | -31.0% |
| 2019 | 40.0% | +14.6% |
| 2020 | 17.1% | -57.2% |
| 2021 | 56.1% | +228.1% |
El Salvador compared with similar countries
- El Salvador's 56.1% is below the median for upper middle income countries, which is 94.5%, 59% of the median. (30 countries reporting)
- El Salvador's 56.1% is below the median for Latin America & Caribbean, which is 91.2%, 62% of the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 32.9% | 9.7% | 61.5% | 8 |
| 2020s | 36.6% | 17.1% | 56.1% | 2 |
Countries ranked near El Salvador
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.9135 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0374 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8849 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antenatal care attendees positive for syphilis who received treatment in El Salvador?
- Antenatal care attendees positive for syphilis who received treatment in El Salvador was 56.1% in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest antenatal care attendees positive for syphilis who received treatment recorded in El Salvador?
- The highest recorded value was 61.5% in 2015.
- What is the lowest antenatal care attendees positive for syphilis who received treatment recorded in El Salvador?
- The lowest recorded value was 9.7% in 2016.
- How does El Salvador rank for antenatal care attendees positive for syphilis who received treatment?
- El Salvador ranks 70th out of 79 countries with data for 2021.
- Is antenatal care attendees positive for syphilis who received treatment rising or falling in El Salvador?
- Over the last ten years it is up 131.8%. The long-run trend across the full record is volatile.
- Where does this El Salvador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Antenatal care attendees positive for syphilis who received treatment (%), reported. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).